Goicoechea, Marian <br/><br/>
Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.  [electronic resource] 

 -  Journal of the American Society of Nephrology : JASN  Dec 2006 
 - S231-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1046-6673 
<br/><br/><label>Standard No.: </label>10.1681/ASN.2006080938  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Atorvastatin<br/>C-Reactive Protein--metabolism<br/>Cardiovascular Diseases--prevention & control<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Dyslipidemias--drug therapy<br/>Female<br/>Fibrinogen--metabolism<br/>Fibrinolysis--drug effects<br/>Heptanoic Acids--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Inflammation--metabolism<br/>Interleukin-6--blood<br/>Kidney Diseases--complications<br/>Lipid Metabolism--drug effects<br/>Male<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--blood<br/>Prospective Studies<br/>Pyrroles--pharmacology<br/>Tissue Plasminogen Activator--blood